These include: the effectiveness of cholinesterase inhibitors, memantine and trazadone as dementia treatments,76, 77 the development of open‐source information extraction tools,78 evaluating the feasibility of using clinical records with the validated suicide risk assessment tool79 to extract patterns pertinent to major depressive disorders,80 and demonstrating the feasibility of using ML models, such as long short‐term memory recurrent neural networks, for personalized treatment recommendations in people with cognitive decline.81 This evidence concerns the gene BCHE and dementia.